Myeloid cell function in MRP-14 (S100A9) null mice

被引:173
|
作者
Hobbs, JAR [1 ]
May, R [1 ]
Tanousis, K [1 ]
McNeill, E [1 ]
Mathies, M [1 ]
Gebhardt, C [1 ]
Henderson, R [1 ]
Robinson, MJ [1 ]
Hogg, N [1 ]
机构
[1] Canc Res UK, Leukocyte Adhes Lab, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England
关键词
D O I
10.1128/MCB.23.7.2564-2576.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloid-related protein 14 (MRP-14) and its heterodimeric partner, NIRP-8, are cytosolic calcium-binding proteins, highly expressed in neutrophils and monocytes. To understand the function of NIRP-14, we performed targeted disruption of the MRP-14 gene in mice. MRP-14(-/-) mice showed no obvious phenotype and were fertile. MRP-8 mRNA but not protein is present in the myeloid cells of these mice, suggesting that the stability of MRP-8 protein is dependent on MRP-14 expression. A compensatory increase in other proteins was not detected in cells lacking MRP-8 and MRP-14. Although the morphology of MRP-14(-/-) myeloid cells was not altered, they were significantly less dense. When Ca2+ responses were investigated, there was no change in the maximal response to the chemokine MIP-2. At lower concentrations, however, there was reduced responsiveness in MRP-14(-/-) compared with MRP-14(+/+) neutrophils. This alteration in the ability to flux Ca2+ did not impair the ability of the MRP-14(-/-) neutrophils to respond chemotactically to MIP-2. In addition, the myeloid cell functions of phagocytosis, superoxide burst, and apoptosis were unaffected in MRP-14(-/-) cells. In an in vivo model of peritonitis, MRP-14(-/-) mice showed no difference from wild-type mice in induced inflammatory response. The data indicate that MRP-14 and MR-P-8 are dispensable for many myeloid cell functions.
引用
收藏
页码:2564 / 2576
页数:13
相关论文
共 50 条
  • [31] Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice
    Eue, I
    Langer, C
    von Eckardstein, A
    Sorg, C
    ATHEROSCLEROSIS, 2000, 151 (02) : 593 - 597
  • [32] Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils
    McNeill, E.
    Conway, S. J.
    Roderick, H. L.
    Bootman, M. D.
    Hogg, N.
    CELL CALCIUM, 2007, 41 (02) : 107 - 121
  • [33] The crystal structure of human MRP14 (S100A9), a Ca2+-dependent regulator protein in inflammatory process
    Itou, H
    Yao, M
    Fujita, I
    Watanabe, N
    Suzuki, M
    Nishihira, J
    Tanaka, I
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 316 (02) : 265 - 276
  • [34] The distribution and expression of S100A8 and S100A9 in gingival epithelium of mice
    Nishii, K.
    Usui, M.
    Yamamoto, G.
    Yajima, S.
    Tsukamoto, Y.
    Tanaka, J.
    Tachikawa, T.
    Yamamoto, M.
    JOURNAL OF PERIODONTAL RESEARCH, 2013, 48 (02) : 235 - 242
  • [35] MYELOID CELL-DERIVED S100A9 MODULATES THE EXPRESSION OF HISTONE METHYLATION EPIGENETIC ENZYMES IN THE MYOCARDIUM AFTER PERMANENT ISCHEMIA IN MICE
    Manea, S. -A.
    Vlad, L. M.
    Mares, R. G.
    Lazar, A. G.
    Preda, B. M.
    Schiopu, A.
    Simionescu, M.
    Manea, A.
    ATHEROSCLEROSIS, 2021, 331 : E34 - E34
  • [36] The human S100 protein MRP-14 is a novel activator of the β2 integrin Mac-1 on neutrophils
    Newton, RA
    Hogg, N
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1427 - 1435
  • [37] S100A8/S100A9: DRIVERS OF DISEASE IN ARTHRITIS BY MYELOID DEFICIENCY OF A20?
    Debusschere, K.
    Cypers, H.
    Vogl, T.
    Roth, J.
    Van Loo, G.
    Drennan, M.
    Elewaut, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 767 - 767
  • [38] S100A9 and tumor growth
    Leanderson, Tomas
    Ivars, Fredrik
    ONCOIMMUNOLOGY, 2012, 1 (08) : 1404 - 1405
  • [39] The Role of S100a9 in the Pathogenesis of Alzheimer's Disease: The Therapeutic Effects of S100a9 Knockdown or Knockout
    Chang, Keun-A
    Kim, Hee Jin
    Suh, Yoo-Hun
    NEURODEGENERATIVE DISEASES, 2012, 10 (1-4) : 27 - 29
  • [40] S100A8 and S100A9 in Cancer
    Chen, Yu
    Ouyang, Yuzhen
    Li, Zhixin
    Wang, Xiufang
    Ma, Jian
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):